Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185991 · ClinicalTrials.gov registry record · NA
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT00185991: Completed NA study, sponsored by Stanford University.
NCT00185991 is a NA study that has completed, run by Stanford University. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185991, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.
Interventions
- DRUG gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2004-06 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00185991 record still lists
NCT00185991 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which gentamicin is the first listed.
NCT00185991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00185991 about?
NCT00185991 is a clinical study titled "Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis". To compare once daily versus 8 hour dosing of gentamicin for the treatment of chorioamnionitis.
What is the current status of trial NCT00185991?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2004-06. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00185991?
The interventions under investigation include: gentamicin (DRUG).
Who is sponsoring clinical trial NCT00185991?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00185991's enrollment target sits among peer trials
126 749th of 2000 higher than 1,248 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia